Biochemical and molecular mechanisms of cisplatin resistance.
Siddik
Zahid H
ZH
Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002945:Cisplatin / Q000627:therapeutic use*; D004247:DNA / Q000378:metabolism; D004249:DNA Damage; D004260:DNA Repair; D019008:Drug Resistance, Neoplasm; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D013438:Sulfhydryl Compounds; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
D000970:Antineoplastic Agents; D019253:Proto-Oncogene Proteins c-bcl-2; D013438:Sulfhydryl Compounds; D016159:Tumor Suppressor Protein p53; D004247:DNA; D005978:Glutathione; D002945:Cisplatin